These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26589093)

  • 1. Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities.
    Butterworth RF
    J Steroid Biochem Mol Biol; 2016 Jun; 160():94-7. PubMed ID: 26589093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma.
    Ahboucha S; Pomier-Layrargues G; Mamer O; Butterworth RF
    Neurochem Int; 2006 Sep; 49(4):372-8. PubMed ID: 16563564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis.
    Ahboucha S; Jiang W; Chatauret N; Mamer O; Baker GB; Butterworth RF
    Neurogastroenterol Motil; 2008 Aug; 20(8):949-57. PubMed ID: 18482252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAA receptor modulating steroid antagonists (GAMSA) are functional in vivo.
    Johansson M; Strömberg J; Ragagnin G; Doverskog M; Bäckström T
    J Steroid Biochem Mol Biol; 2016 Jun; 160():98-105. PubMed ID: 26523675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2007 Dec; 22(3-4):291-308. PubMed ID: 17823858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy.
    Jones EA
    Metab Brain Dis; 2002 Dec; 17(4):275-81. PubMed ID: 12602504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Neurochem Int; 2008; 52(4-5):575-87. PubMed ID: 17610999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy.
    Ahboucha S; Pomier-Layrargues G; Butterworth RF
    Metab Brain Dis; 2004 Dec; 19(3-4):241-51. PubMed ID: 15554420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons.
    Ahboucha S; Coyne L; Hirakawa R; Butterworth RF; Halliwell RF
    Neurochem Int; 2006 Jun; 48(8):703-7. PubMed ID: 16487630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GR3027 antagonizes GABAA receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy.
    Johansson M; Agusti A; Llansola M; Montoliu C; Strömberg J; Malinina E; Ragagnin G; Doverskog M; Bäckström T; Felipo V
    Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(5):G400-9. PubMed ID: 26138462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of GABAA receptors by neurosteroids. A new concept to improve cognitive and motor alterations in hepatic encephalopathy.
    Agusti A; Llansola M; Hernández-Rabaza V; Cabrera-Pastor A; Montoliu C; Felipo V
    J Steroid Biochem Mol Biol; 2016 Jun; 160():88-93. PubMed ID: 26307490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAergic neurosteroids: the "endogenous benzodiazepines" of acute liver failure.
    Ahboucha S; Gamrani H; Baker G
    Neurochem Int; 2012 Jun; 60(7):707-14. PubMed ID: 22041164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy.
    Butterworth RF
    Neurochem Int; 2010 Nov; 57(4):383-8. PubMed ID: 20350577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.
    Carver CM; Reddy DS
    Psychopharmacology (Berl); 2013 Nov; 230(2):151-88. PubMed ID: 24071826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current theories on the pathogenesis of hepatic encephalopathy.
    Mousseau DD; Butterworth RF
    Proc Soc Exp Biol Med; 1994 Sep; 206(4):329-44. PubMed ID: 7915420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurosteroids and hepatic encephalopathy: an update on possible pathophysiologic mechanisms.
    Ahboucha S
    Curr Mol Pharmacol; 2011 Jan; 4(1):1-13. PubMed ID: 20825363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy.
    Ahboucha S; Desjardins P; Chatauret N; Pomier-Layrargues G; Butterworth RF
    Neurochem Int; 2003 Nov; 43(6):551-6. PubMed ID: 12820983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAergic transmission in hepatic encephalopathy.
    Sergeeva OA
    Arch Biochem Biophys; 2013 Aug; 536(2):122-30. PubMed ID: 23624382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced brain levels of DHEAS in hepatic coma patients: significance for increased GABAergic tone in hepatic encephalopathy.
    Ahboucha S; Talani G; Fanutza T; Sanna E; Biggio G; Gamrani H; Butterworth RF
    Neurochem Int; 2012 Jul; 61(1):48-53. PubMed ID: 22490610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2004 Dec; 19(3-4):331-43. PubMed ID: 15554425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.